Search

Displaying results 7931 - 7940 of 10000 in total
  1. Drug

    Pulrodemstat

    go.drugbank.com/drugs/DB21497
    Experimental

    Pulrodemstat is a small molecule drug. The usage of the INN stem '-demstat' in the name indicates that Pulrodemstat is a Lysine-specific histone demethylase inhibitor.

  2. Drug

    Zavolosotine

    go.drugbank.com/drugs/DB21531
    Experimental

    Zavolosotine is a small molecule drug. The usage of the INN stem '-sotine' in the name indicates that Zavolosotine is a non-peptidic somatostatin receptor agonist.

  3. Drug

    Branosotine

    go.drugbank.com/drugs/DB21674
    Experimental

    Branosotine is a small molecule drug. The usage of the INN stem '-sotine' in the name indicates that Branosotine is a non-peptidic somatostatin receptor agonist.

  4. Drug

    Masilukast

    go.drugbank.com/drugs/DB16227
    Investigational

    Masilukast is under investigation in clinical trial NCT01740986 (Safety and Efficacy of SA09012 in Asthma).

  5. Drug

    Petesicatib

    go.drugbank.com/drugs/DB15297
    Investigational

    Petesicatib is under investigation in clinical trial NCT02295332 (A Study of RG7625 in Healthy Volunteers).

  6. Drug

    Amylopectin

    go.drugbank.com/drugs/DB14927
    Experimental

    Amylopectin is under investigation in clinical trial NCT01708694 (Role of Slowly Digesible Starch on Diabetes Risk Factors).

  7. Drug

    Cafedrine

    go.drugbank.com/drugs/DB12926
    Investigational

    Cafedrine is under investigation in clinical trial NCT01311414 (Effect of Cafedrine/Theodrenaline and Urapidil on Cerebral Oxygenation).

  8. Drug

    Theodrenaline

    go.drugbank.com/drugs/DB12927
    Investigational

    Theodrenaline is under investigation in clinical trial NCT01311414 (Effect of Cafedrine/Theodrenaline and Urapidil on Cerebral Oxygenation).

  9. Drug

    Lefradafiban

    go.drugbank.com/drugs/DB04863
    Investigational

    Lefradafiban is an oral platelet glycoprotein IIb/IIIa receptor antagonist being investigated in the treatment of angina.

  10. Drug

    Devafidugene civaparvovec

    go.drugbank.com/drugs/DB16790
    Investigational

    Devafidugene civaparvovec is an investigational _in vivo_ genome editing product. … Developed by Sangamo Therapeutics, Inc., devafidugene civaparvovec is being investigated for the treatment of mucopolysaccharidosis Type I (MPS I).[L46716]